Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli

Fosfomycin has become a therapeutic option in urinary tract infections. Our objective was to evaluate the in vitro activity of fosfomycin against Escherichia coli isolated from urine samples in 2013, 2018 and 2021. We also determined a putative association between fosfomycin resistance and extended-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ríos, Esther, del Carmen López Diaz, María, Culebras, Esther, Rodríguez-Avial, Iciar, Rodríguez-Avial, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618510/
https://www.ncbi.nlm.nih.gov/pubmed/36056943
http://dx.doi.org/10.1007/s00430-022-00749-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618510/
https://www.ncbi.nlm.nih.gov/pubmed/36056943
http://dx.doi.org/10.1007/s00430-022-00749-2

Ejemplares similares